The biggest stories of the day delivered to your inbox.

EPC, the leader in GaN, announces the release of its Phase 17 Reliability Report, further solidifying GaN’s position as a highly reliable technology. The latest reliability report introduces expanded ...

CHICAGO, April 21, 2026 /PRNewswire/ -- Ractigen Therapeutics, a clinical-stage biopharmaceutical company focused on developing next-generation RNA-based medicines, today announced positive ...